Moreover, treatment with ACY-738 (an HDAC inhibitor selective for class I HDACs and HDAC6 [24, 67]) demonstrated a more beneficial effect on survival in males compared to females in an ALS mouse model [68]. This evidence concerns the gene HDAC6 and amyotrophic lateral sclerosis.